AbbVie gets FDA approval for Rinvoq to treat ankylosing spondylitis
The FDA approval is supported by safety and efficacy findings from the Phase III SELECT-AXIS 2 and Phase…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 May 22
The FDA approval is supported by safety and efficacy findings from the Phase III SELECT-AXIS 2 and Phase…
29 Apr 22
Camzyos is said to be the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source…
29 Apr 22
With the approval, Ultomiris becomes the first and only long-acting C5 complement inhibitor to be approved in the…
28 Apr 22
Vydura is indicated for acute treatment of migraine regardless of aura, and prophylaxis (prevention) of episodic migraine in…
26 Apr 22
Veklury is indicated for patients who are admitted to the hospital or have a mild-to-moderate disease and are…
25 Apr 22
The company’s decision to withdraw follows consultation with the CHMP, which suggested that the data provided so far…
19 Apr 22
The British drugmaker’s regulatory submission was based on the Phase 3 ASCEND clinical trial programme, where all the…
19 Apr 22
Nuvaxovid is the first recombinant protein-based Covid-19 vaccine approved in Japan and is based on efficacy and safety…
18 Apr 22
Spikevax was previously authorised by the MHRA for use in adults aged 18 years and above, and for…
13 Apr 22
ExoFlo is an acellular human bone marrow mesenchymal stem cell (MSC) obtained EV product developed leveraging Direct Biologics’…